Page last updated: 2024-08-24

capecitabine and Hepatitis B Virus Infection

capecitabine has been researched along with Hepatitis B Virus Infection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Eminler, AT; Hacibekiroglu, I; Karacaer, C; Koksal, AS; Toka, B; Tozlu, M; Uslan, MI1
Brandi, G; Brocchi, S; De Lorenzo, S; Di Federico, A; Frega, G; Golfieri, R; Morelli, MC; Palloni, A; Rizzo, A; Vasuri, F1

Reviews

1 review(s) available for capecitabine and Hepatitis B Virus Infection

ArticleYear
Hepatitis B reactivation after oral capecitabine treatment in a rectum cancer patient with isolated anti-HBc IgG positivity.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:5

    Topics: Capecitabine; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulin G; Male; Middle Aged; Rectal Neoplasms

2022

Other Studies

1 other study(ies) available for capecitabine and Hepatitis B Virus Infection

ArticleYear
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma.
    Anti-cancer drugs, 2022, 01-01, Volume: 33, Issue:1

    Topics: Administration, Metronomic; Adult; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis D; Humans; Liver Neoplasms; Male; Patient Acuity

2022